SPOTLIGHT: Docs say dementia drugs created equal

In issuing new dementia-treatment guidelines, two big doctors' groups contended that none of the five treatments is better than the rest and asked for more research on the meds, including head-to-head testing of drug combos. Report | Guidelines

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.